ArticleFEBS open bio2020
NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer.
Lu Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleFEBS open bio2020
Lu Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.